[Effect of low molecular weight heparin on unstable angina].
OBJECTIVE
To evaluate the effect of low molecular weight heparin (LMWH) and verus urokinase (UK) on unstable angina (UA).


METHODS
Sixty seven patients with UA were divided in two groups by a single blind, controlled, randomized method: LMWH (anti-thrombi) group and UK (thromblytic therapy) group. Total ischemia load in 24 hours ambulatory ECG, mortality and cases of acute myocardial infarction (AMI) in 30 days were employed to compare the effect and safety between two groups.


RESULTS
There was no significant difference in decreasing attacks of angina pectoris and total ischemia load between two groups. The UK group had two cases of AMI and five cases of complications of bleeding (two cases of epistaxis, two cases of bleeding gums, one case of hematochezia).


CONCLUSIONS
Antithrombin therapy is prior to thromblitic therapy, treatment of LMWH is safer than that of low dose UK in UA.
Jiang
D Q
DQ
Department of Cardiology, Second Xinagya Hospital, Central South University, Changsha 410011, China.
Wen
D
D
Zhou
S H
SH
D000789:Angina, Unstable / Q000188:drug therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016037:Single-Blind Method
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight